UK's MHRA Says Resmetirom (Rezdiffra) Authorized To Treat Metabolic Dysfunction-Associated Steatohepatitis In Adults

Benzinga Newsdesk Jun 3, 2026 5 months ago

BiotechNewsGeneral

Full article content is not available on this page. Continue to benzinga.com to read the original report.